Counteracting effects of renal solutes on amyloid fibril formation by immunoglobulin light chains

被引:80
作者
Kim, YS
Cape, SP
Chi, E
Raffen, R
Wilkins-Stevens, P
Stevens, FJ
Manning, MC
Randolph, TW
Solomon, A
Carpenter, JF [1 ]
机构
[1] Univ Colorado, Hlth Sci Ctr, Sch Pharm, Dept Pharmaceut Sci, Denver, CO 80262 USA
[2] Univ Colorado, Dept Chem Engn, Boulder, CO 80309 USA
[3] Argonne Natl Lab, Biosci Div, Argonne, IL 60439 USA
[4] Univ Tennessee, Human Immunol & Canc Program, Grad Sch Med, Knoxville, TN 37920 USA
关键词
D O I
10.1074/jbc.M007766200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In primary (light chain-associated) amyloidosis, immunoglobulin light chains deposit as amyloid fibrils in vital organs, especially the kidney. Because the kidney contains high concentrations of urea that can destabilize light chains as well as solutes such as betaine and sorbitol that serve as protein stabilizers, we investigated the effects of these solutes on in vitro amyloid fibril formation and thermodynamic stability of light chains, Two recombinant light chain proteins, one amyloidogenic and the other nonamyloidogenic, were used as models, For both light chains, urea enhanced fibril formation by reducing the nucleation lag time and diminished protein thermodynamic stability. Conversely, betaine or sorbitol increased thermodynamic stability of the proteins and partially inhibited fibril formation. These solutes also counteracted urea-induced reduction in protein thermodynamic stability and accelerated fibril formation. Betaine was more effective than sorbitol. A model is presented to explain how the thermodynamic effects of the solutes on protein state equilibria can alter nucleation lag time and, hence, fibril formation kinetics. Our results provide evidence that renal solutes control thermodynamic and kinetic stability of light chains and thus may modulate amyloid fibril formation in the kidney.
引用
收藏
页码:1626 / 1633
页数:8
相关论文
共 47 条
[21]   Thermodynamic modulation of light chain amyloid fibril formation [J].
Kim, YS ;
Wall, JS ;
Meyer, J ;
Murphy, C ;
Randolph, TW ;
Manning, MC ;
Solomon, A ;
Carpenter, JF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (03) :1570-1574
[22]  
KYLE RA, 1995, SEMIN HEMATOL, V32, P45
[23]  
KYLE RA, 1994, ANNU REV MED, V45, P71
[24]  
MARSH DJ, 1992, RENAL PHYSL, P1317
[25]   COMPARISON OF LETHAL AND NONLETHAL TRANSTHYRETIN VARIANTS AND THEIR RELATIONSHIP TO AMYLOID DISEASE [J].
MCCUTCHEN, SL ;
LAI, ZH ;
MIROY, GJ ;
KELLY, JW ;
COLON, W .
BIOCHEMISTRY, 1995, 34 (41) :13527-13536
[26]   PATHOGENIC POTENTIAL OF HUMAN MONOCLONAL IMMUNOGLOBULIN LIGHT-CHAINS - RELATIONSHIP OF IN-VITRO AGGREGATION TO IN-VIVO ORGAN DEPOSITION [J].
MYATT, EA ;
WESTHOLM, FA ;
WEISS, DT ;
SOLOMON, A ;
SCHIFFER, M ;
STEVENS, FJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (08) :3034-3038
[27]   FLUOROMETRIC-DETERMINATION OF AMYLOID FIBRILS INVITRO USING THE FLUORESCENT DYE, THIOFLAVINE-T [J].
NAIKI, H ;
HIGUCHI, K ;
HOSOKAWA, M ;
TAKEDA, T .
ANALYTICAL BIOCHEMISTRY, 1989, 177 (02) :244-249
[28]  
Pace C N, 1986, Methods Enzymol, V131, P266
[29]  
Raffen R, 1999, PROTEIN SCI, V8, P509
[30]  
RONCO PM, 1997, DIS KIDNEY, V3, P2129